Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
A new version of tool called a fiberscope, which will let surgeons treat even more lung cancer patients using cutting-edge photothermal therapy, has been developed by researchers at UHN's Techna and Princess Margaret Cancer Centre, in collaboration with a Japanese company.
The fiberscope channels light from a laser deep into the lungs. There, that light is converted into cancer-cell-killing heat by special chemicals injected into the tumour.
Photothermal therapy is being improved through development of nanoparticles called porphysomes. These next-generation biodegradable nanoparticles accumulate in tumours, where they convert light to heat. The small particles also fluoresce, giving off special light that can guide surgeons to the tumour.
A current challenge is that two separate optical fibres are required: one to visualize and find the tumour, and one to deliver the laser light. Once the first fibre is used to find the tumour, repositioning the second fibre increases the chance of missing the tumour.
Another challenge is presented by how the airways in the lung branch and become narrower. Current fiberscopes, limited by their size and lack of flexibility, can only reach about two branches in.
That limitation means that photothermal therapy can be challenging for tumours that are located deep in the lung.
The new fiberscope – developed by Dr. Kazuhiro Yasufuku at UHN and OK Fibre Technology Co. of Japan – addresses these issues.
It combines two types of optical fibres into a single scope, which can locate the tumour and target it with photothermal therapy. It is also smaller and more flexible, allowing the team to treat tumours that are approximately six centimeters deeper in the lung, or about six to nine branches inside the airway.
"This research is a great example of how innovative partnerships based on UHN technology can help patients," says Dr. Yasufuku. "The technology has the potential to greatly improve access to this cutting edge and minimally invasive anticancer therapy."
This work was supported by the Canadian Cancer Society Research Institute, the Terry Fox Research Institute, the Canadian Institutes of Health Research, the National Sanitarium Association and The Princess Margaret Cancer Foundation.